During the last three months, 15 analysts shared their evaluations of Baker Hughes BKR, revealing diverse outlooks from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 8 | 5 | 2 | 0 | 0 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 6 | 4 | 1 | 0 | 0 |
2M Ago | 2 | 1 | 0 | 0 | 0 |
3M Ago | 0 | 0 | 0 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $43.73, along with a high estimate of $50.00 and a low estimate of $38.00. This current average has increased by 5.96% from the previous average price target of $41.27.
Interpreting Analyst Ratings: A Closer Look
The perception of Baker Hughes by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Josh Silverstein | UBS | Raises | Neutral | $42.00 | $40.00 |
James West | Evercore ISI Group | Raises | Outperform | $46.00 | $42.00 |
Marc Bianchi | TD Cowen | Raises | Buy | $50.00 | $46.00 |
Kurt Hallead | Benchmark | Raises | Buy | $42.00 | $40.00 |
Neil Mehta | Goldman Sachs | Raises | Buy | $43.00 | $39.00 |
Sean Meakim | JP Morgan | Raises | Overweight | $43.00 | $42.00 |
Lloyd Byrne | Jefferies | Raises | Buy | $48.00 | $46.00 |
Keith Mackey | RBC Capital | Raises | Outperform | $43.00 | $39.00 |
Roger Read | Wells Fargo | Raises | Equal-Weight | $40.00 | $35.00 |
Charles Minervino | Susquehanna | Raises | Positive | $46.00 | $40.00 |
Stephen Gengaro | Stifel | Raises | Buy | $45.00 | $40.00 |
Kurt Hallead | Benchmark | Maintains | Buy | $40.00 | $40.00 |
Saurabh Pant | B of A Securities | Lowers | Buy | $38.00 | $40.00 |
Luke Lemoine | Piper Sandler | Lowers | Overweight | $44.00 | $45.00 |
Lloyd Byrne | Jefferies | Raises | Buy | $46.00 | $45.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Baker Hughes. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Baker Hughes compared to the broader market.
- Price Targets: Analysts predict movements in price targets, offering estimates for Baker Hughes's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.
Capture valuable insights into Baker Hughes's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Baker Hughes analyst ratings.
About Baker Hughes
Baker Hughes is a global leader in oilfield services and oilfield equipment, with particularly strong presences in the artificial lift, specialty chemicals, and completions markets. It maintains modest exposure to offshore oil and gas production. The other half of its business focuses on industrial power generation, process solutions, and industrial asset management, with a high exposure to the liquid natural gas market specifically, as well as broader industrials end markets.
Financial Milestones: Baker Hughes's Journey
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Positive Revenue Trend: Examining Baker Hughes's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 13.05% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Energy sector.
Net Margin: Baker Hughes's net margin excels beyond industry benchmarks, reaching 8.11%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Baker Hughes's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 3.74%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Baker Hughes's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.57%, the company showcases efficient use of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 0.38, Baker Hughes adopts a prudent financial strategy, indicating a balanced approach to debt management.
Analyst Ratings: What Are They?
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.